PELTHOS THERAPEUTICS INC.
Last · NYSE$20.25-0.04 (-0.20%)close · yahoo · 16h ago
Market cap$77.53M3.8M sh
P/E · TTM-0.7fwd -3.6 · eps -27.53 · loss
Beta3.11vs S&P 500
Div yield0.00%annual · TTM
52w range
$18.19$37.50
Volume44.5Ksession
| Revenue | $26.5M |
|---|---|
| Operating income | $-30.4M |
| Net income | $-48.5M |
| Free cash flow | $-21.0M |
| Operating margin | -114.7% |
| Net margin | -182.9% |
| Period | 2026 |
Loading chart…
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$3.06
Est. revenue
17.6M
Earnings transcripts
Press & signals
- GlobeNewswire
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
- GlobeNewswire
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
- GlobeNewswire
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags